Prostate cancer is the most common form of cancer among men in England, with cases surging by 25 per cent between 2019 and 2023, according to NHS data. It’s also the second-deadliest form of the ...
Add Yahoo as a preferred source to see more of our stories on Google. Prostate cancer blood tests can lead to men being over-tested, while those who need help may be missed, a large study has found.
To check for possible prostate cancer, physicians most often use prostate-specific antigen (PSA) tests and digital rectal exams (DREs). For a firm diagnosis, they use core needle biopsies. This page ...
Prostate cancer is one of the most common cancers in the world. While many prostate cancers grow slowly and remain localized, other types are aggressive and spread quickly. That's why Dr. Carlos ...
WASHINGTON D.C. (WPVI) -- The Preventive Services Task Force is changing recommendations that can affect millions of middle-aged men. Five years ago, it opposed routine screening for prostate cancer, ...
About one in every three men who have a positive blood test for prostate cancer are unlikely to develop the disease and may instead suffer problems from unnecessary surgeries or treatment, according ...
Prostate cancer affects one in eight men in the U.S. over their lifetime, which is the same rate as women and breast cancer.
A new at-home saliva test for prostate cancer could outperform current testing methods, a new study suggests. Researchers have developed a simple spit test, that can be performed at home and does not ...
Hosted on MSN
Call for more tests to screen for prostate cancer
A charity providing free prostate cancer tests has called for more NHS screening to reduce the number of men who go undiagnosed. The Torbay Prostate Support Association (TPSA) said men who had the ...
A portable and rapid prostate cancer screening kit developed by Cornell University researchers could provide early warning to populations with higher incidence of prostate cancer and limited ...
Myriad Genetics Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) has approved the use ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results